loader
Please Wait
Applying Filters...
menu
    • menu

    Digital Content for Sodium

    Client Email Product
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Bora Pharmaceuticals- Making success more certain.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Virtual Booth

    Contact Supplier

    Axplora- The partner of choice for complex APIs.

    Virtual Booth

    Contact Supplier

    Fareva is a one-stop-shop for API/HPAPI, OSD & Sterile products, is USFDA, EMA and PMDA-inspected and has multiple NDA & ANDA filings.

    Virtual Booth

    Contact Supplier

    Menu

    Sodium

    ACTIVE PHARMA INGREDIENTS

    PRICE INFORMATION

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    PharmaCompass
    $ API Ref.Price (USD/KG) : 36Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    American Regent Introduces FDA-Approved Sodium Phosphates Injection
    American Regent Introduces FDA-Approved Sodium Phosphates Injection

    02 Jul 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/american-regent-introduces-sodium-phosphates-injection-usp-fda-approved-and-ap-rated-302187998.html

    PR NEWSWIRE
    02 Jul 2024
    Share Share
    Enforcement Report - Week of August 24, 2022
    Enforcement Report - Week of August 24, 2022

    24 Aug 2022

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-august-24-2022-1661335123.pdf

    FDA
    24 Aug 2022
    Share Share
    FDA Confirms Para IV Patent Litigation for Sodium Zirconium Cyclosilicate oral suspension
    FDA Confirms Para IV Patent Litigation for Sodium Zirconium Cyclosilicate oral suspension

    26 Jul 2022

    // FDA

    https://www.pharmacompass.com/pdf/news/fda-confirms-para-iv-patent-litigation-for-sodium-zirconium-cyclosilicate-oral-suspension-1659342921.pdf

    FDA
    26 Jul 2022
    Share Share
    FDA Grants ODE for Xywav Oral Solution for Idiopathic Hypersomnia in Adults
    FDA Grants ODE for Xywav Oral Solution for Idiopathic Hypersomnia in Adults

    03 Jan 2022

    // BIOSPACE

    https://www.biospace.com/article/releases/u-s-fda-grants-orphan-drug-exclusivity-ode-for-xywav-calcium-magnesium-potassium-and-sodium-oxybates-oral-solution-for-idiopathic-hypersomnia-in-adults/

    BIOSPACE
    03 Jan 2022
    Share Share
    Baxter Healthcare's Chemical Heparin Sodium and Sodium Chloride Receives Approval in the U.S.
    Baxter Healthcare's Chemical Heparin Sodium and Sodium Chloride Receives Approval in the U.S.

    03 Jan 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=018609

    FDA
    03 Jan 2022
    Share Share